Integral Molecular In response to the COVID-19 pandemic, AboundBio developed potent neutralizing monoclonal antibodies (MAbs) against SARS-CoV-2.
Integral Molecular News
MPA – How the Membrane Proteome Array Enabled Rapid Progression of a Neutralizing SARS-CoV-2 MAb
- November 16, 2020
Upcoming Events
World Vaccine Congress US
4/3 – 4/6 | Washington, DC
AACR Annual Meeting 2023
4/14 – 4/19 | Orlando, FL
PEGS Boston 2023
5/15 – 5/19 | Boston, MA
